InGel Therapeutics, Inc. Information
Contact top employees from
InGel Therapeutics, Inc.
Summary
InGel Therapeutics is Harvard-spinoff, regenerative medicine biotech leveraging novel neuroprotective mechanisms to stop retinal degeneration. Our beachhead indication is Retinitis Pigmentosa, with fu...Show more
Industries
Biotechnology
Headquarters Location
Employees Size
1-10 employees
Founded
2022
Employees Turnover 3 quarter 2025
Length of Employment
Employee tenure at InGel Therapeutics, Inc. shows a diverse range of experience levels:
20% have been with the company for less than 1 year60% for 1–2 years20% for 3–4 yearsContact top employees from
InGel Therapeutics, Inc.
Patrick Jiang
Co-founder and Chief Business Officer
Deepti Singh
Founder and Chief Scientific Officer
Pierre Colombe Dromel
CTO and Co-founder
